Enhancement of Tissue Plasminogen Activator-Catalyzed Plasminogen Activation by Escherichia coii S Fimbriae Associated with Neonatal Septicaemia and Meningitis

Summary

The effect of Escherichia coli strains isolated from blood and cerebrospinal fluid of septic infants on plasminogen activation was studied. These strains typically carry a filamentous surface protein, S fimbria, that has formerly been shown to bind to endothelial cells and interact with plasminogen. The bacteria effectively promoted plasminogen activation by tissue plasminogen activator (t-PA) which was inhibited by s-aminocaproic acid. A recombinant strain expressing S fimbriae accelerated t-PA-catalyzed plasminogen activation to a similar extent as did the wild-type strains whereas the nonfimbriate recipient strain had no effect. After incubation with t-PA and plasminogen, the S-fimbriate strain displayed bacterium-bound plasmin activity whereas the nonfimbriate strain did not. Bacterium-associated plasmin generation was also observed with a strain expressing mutagenized S fimbriae that lack the cell-binding subunit SfaS but not with a strain lacking the major subunit SfaA. Both t-PA and plasminogen bound to purified S fimbriae in a lysine-dependent manner and purified S fimbriae accelerated t-PA-catalyzed plasminogen activation. The results indicate that E. coli S fimbriae form a complex with t-PA and plasminogen which enhances the rate of plasminogen activation and generates bacterium-bound plasmin. This may promote bacterial invasion and persistence in tissues and contribute to the systemic activation of fibrinolysis in septicaemia.

• References

• 1 Aasen AO, Smith-Erichsen N, Amundsen E. Studies on pathological plasma proteolysis in patients with septicemia. Scand J Clin Lab Invest 1985; 45: 37-45
• 2 Colman RW. The role of plasma proteases in septic shock. N Engl J Med 1989; 320: 1207-1209
• 3 Suffredini AF, Harpel PC, Parrillo JE. Promotion and subsequent inhibition of plasminogen activation after administration of intravenous endotoxin to normal subjects. N Engl J Med 1989; 320: 1165-1172
• 4 Brandzaeg P, Joø GB, Brusletto B, Kierulf P. Plasminogen activator inhibitor 1 and 2, alpha-2-antiplasmin, plasminogen, and endotoxin in systemic meningococcal disease. Thromb Res 1990; 57: 271-278
• 5 Hoylaerts M, Rijken DC, Lijnen HR, Collen D. Kinetics of the activation of plasminogen by human tissue plasminogen activator. Role of fibrin. J Biol Chem 1982; 257: 2912-2919
• 6 Wiman B, Wallen D. The specific interaction between plasminogen and fibrin. A physiological role of the lysine binding site in plasminogen. Thromb Res 1977; 10: 213-222
• 7 van Zonneveld A-J, Veerman H, Pannekoek H. On the interaction of the finger and the kringle-2 domain of tissue-type plasminogen activator with fibrin. Inhibition of kringle-2 binding to fibrin by 8-aminocaproic acid. J Biol Chem 1986; 261: 14214-14218
• 8 Verheijen JH, Caspers MPM, Chang GTG, de Munk GAW, Pouwels PH, Enger-Valk BE. Involvement of finger domain and kringle 2 domain of tissue-type plasminogen activator in fibrin binding and stimulation of activity by fibrin. Embo J 1986; 5: 3525-3530
• 9 Parkkinen J, Korhonen TK. Binding of plasminogen to Escherichia coli adhesion proteins. FEBS Lett 1989; 250: 437-440
• 10 Ullberg M, Kronvall G, Karlsson I, Wiman B. Receptors for human plasminogen on Gram-negative bacteria. Infect Immun 1990; 58: 21-25
• 11 Korhonen TK, Valtonen MV, Parkkinen J. et al Serotypes, hemolysin production, and receptor recognition of Escherichia coli strains associated with neonatal sepsis and meningitis. Infect Immun 1985; 48: 486-491
• 12 Saukkonen KM, Nowicki JB, Leinonen M. Role of type 1 and S fimbriae in the pathogenesis of Escherichia coli O18 :K1 bacteremia and meningitis in the infant rat. Infect Immun 1988; 56: 892-897
• 13 Parkkinen J, Ristimäki A, Westerlund B. Binding of Escherichia coli S fimbriae to cultured human endothelial cells. Infect Immun 1989; 57: 2256-2259
• 14 Parkkinen J, Korhonen TK, Pere A, Hacker J, Soinila S. Binding sites in the rat brain for Escherichia coli S fimbriae associated with neonatal meningitis. J Clin Invest 1988; 81: 860-865
• 15 Schmoll T, Hoschützky H, Morschhäuser J, Lottspeich F, Jann K, Hacker J. Analysis of genes for the sialic acid-binding adhesin and two other minor fimbrial subunits of the S-fimbrial adhesin determinant of Escherichia coli . Mol Microbiol 1989; 3: 1735-1744
• 16 Pere A, Nowicki B, Saxen H, Siitonen A, Korhonen TK. Expression of P, Type-1, and Type-1C fimbriae of Escherichia coli in the urine of patients with acute urinary tract infection. J Infect Dis 1987; 156: 567-574
• 17 Korhonen TK, Väisänen-Rhen V, Rhen M, Pere A, Parkkinen J, Finne J. Escherichia coli fimbriae recognizing sialyl galactosides. J Bacteriol 1985; 159: 762-766
• 18 Voskuilen M, Vermond A, Veeneman GH, van Boom JH, Klasen EA, Zegers ND, Nieuwenhuizen W. Fibrinogen lysine residue Aαl57 plays a crucial role in the fibrin-induced acceleration of plasminogen activation, catalyzed by tissue-type plasminogen activator. J Biol Chem 1987; 262: 5944-5946
• 19 Moch T, Hoschützkü H, Hacker J, Kröncke K-D, Jann K. Isolation and characterization of the α-sialyl-β-2,3-galactosyl-specific adhesin from fimbriated Escherichia coli . Proc Natl Acad Sci USA 1987; 84: 3462-3466
• 20 Morrison DC, Ryan JL. Endotoxins and disease mechanism. Annu Rev Med 1987; 38: 417-432
• 21 Hekman CM, Loskutoff DJ. Fibrinolytic pathways and the endothelium. Sem Thromb Hemostas 1987; 13: 514-527
• 22 Danø K, Andreasen PA, Grøndahl-Hansen J, Kristensen P, Nielsen LS, Skriver L. Plasminogen activators, tissue degradation, and cancer. Adv Cancer Res 1985; 44: 140-266
• 23 Mignatti P, Robbins E, Rifkin DB. Tumor invasion through the human amniotic membrane: Requirement for a proteinase cascade. Cell 1986; 47: 487-498
• 24 Tryggvason K, Höyhtyä M, Salo T. Proteolytic degradation of extracellular matrix in tumor invasion. Biochim Biophys Acta 1987; 907: 191-217